Susanne Fritsch

1.3k total citations
26 papers, 946 citations indexed

About

Susanne Fritsch is a scholar working on Hematology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Susanne Fritsch has authored 26 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Epidemiology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Susanne Fritsch's work include Cerebrovascular and Carotid Artery Diseases (8 papers), Acute Ischemic Stroke Management (8 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Susanne Fritsch is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (8 papers), Acute Ischemic Stroke Management (8 papers) and Hematopoietic Stem Cell Transplantation (8 papers). Susanne Fritsch collaborates with scholars based in Germany, United States and Ireland. Susanne Fritsch's co-authors include Colin P. Derdeyn, William J. Powers, Robert L. Grubb, David A. Carpenter, Kent D. Yundt, Tom O. Videen, David Carpenter, Anil Khosla, Johanna Tischer and Andreas Hausmann and has published in prestigious journals such as Blood, Brain and Neurology.

In The Last Decade

Susanne Fritsch

22 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanne Fritsch Germany 14 476 378 285 285 187 26 946
Ronald Alberico United States 20 321 0.7× 305 0.8× 684 2.4× 246 0.9× 97 0.5× 46 1.3k
Bruce L. Dean United States 17 557 1.2× 454 1.2× 901 3.2× 379 1.3× 43 0.2× 34 1.7k
M. Cellerini Italy 17 146 0.3× 229 0.6× 309 1.1× 258 0.9× 48 0.3× 49 873
Wajanat Jan United Kingdom 16 250 0.5× 169 0.4× 395 1.4× 171 0.6× 39 0.2× 41 1.1k
Moshe Snir Israel 21 206 0.4× 191 0.5× 183 0.6× 472 1.7× 36 0.2× 70 1.1k
J Roland France 19 350 0.7× 259 0.7× 258 0.9× 58 0.2× 23 0.1× 71 975
Axel Scherer Germany 18 135 0.3× 108 0.3× 91 0.3× 303 1.1× 68 0.4× 40 1.1k
Patrizia Nencini Italy 17 250 0.5× 359 0.9× 323 1.1× 45 0.2× 70 0.4× 42 876
Jean‐Marc Dumollard France 16 300 0.6× 58 0.2× 100 0.4× 218 0.8× 30 0.2× 44 919
D. W. Laster United States 17 118 0.2× 164 0.4× 574 2.0× 145 0.5× 40 0.2× 37 1.1k

Countries citing papers authored by Susanne Fritsch

Since Specialization
Citations

This map shows the geographic impact of Susanne Fritsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Fritsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Fritsch more than expected).

Fields of papers citing papers by Susanne Fritsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Fritsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Fritsch. The network helps show where Susanne Fritsch may publish in the future.

Co-authorship network of co-authors of Susanne Fritsch

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Fritsch. A scholar is included among the top collaborators of Susanne Fritsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Fritsch. Susanne Fritsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fraccaroli, Alessia, Dušan Prevalšek, Susanne Fritsch, et al.. (2018). Sequential HLA‐haploidentical transplantation utilizing post‐transplantation cyclophosphamide for GvHD prophylaxis in high‐risk and relapsed/refractory AML/MDS. American Journal of Hematology. 93(12). 1524–1531. 16 indexed citations
2.
Fraccaroli, Alessia, Dušan Prevalšek, Veit Bücklein, et al.. (2018). Favorable Outcome of Sequential HLA-Haploidentical Transplantation Using Ptcy As GvHD Prophylaxis in High Risk AML and MDS of the Elderly. Blood. 132(Supplement 1). 3458–3458.
3.
Hubmann, Max, Susanne Fritsch, Dušan Prevalšek, et al.. (2016). Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation. Journal of Clinical Virology. 82. 33–40. 21 indexed citations
4.
Fritsch, Susanne & Herbert Günther. (2016). Inklusion: So geht das. 1 indexed citations
5.
Fritsch, Susanne, Dušan Prevalšek, Nicole Engel, et al.. (2015). Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma. Bone Marrow Transplantation. 50(5). 679–684. 16 indexed citations
6.
Tischer, Johanna, Nicole Engel, Susanne Fritsch, et al.. (2015). Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings. Annals of Hematology. 94(10). 1677–1688. 54 indexed citations
7.
8.
Tischer, Johanna, Nicole Engel, Susanne Fritsch, et al.. (2014). Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation. Bone Marrow Transplantation. 49(7). 895–901. 32 indexed citations
9.
Tischer, Johanna, Hans‐Joachim Stemmler, Nicole Engel, et al.. (2013). Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia. Annals of Hematology. 92(10). 1379–1388. 24 indexed citations
10.
11.
Schneider, Friederike, Eva Hoster, Michael Unterhalt, et al.. (2009). NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS). Blood. 113(21). 5250–5253. 48 indexed citations
12.
Fritsch, Susanne, Christian Buske, Bernhard Wörmann, et al.. (2007). Die Therapie der akuten myeloischen Leukämie (AML) bei „medically non-fit“ Patienten. Medizinische Klinik. 102(4). 324–329. 2 indexed citations
13.
Fritsch, Susanne, Klaus H. Metzeler, Wolfgang Hiddemann, & Christian Buske. (2006). Diagnose und Therapie der akuten myeloischen Leukämie. DMW - Deutsche Medizinische Wochenschrift. 131(43). 2401–2406. 1 indexed citations
14.
Derdeyn, Colin P., Kent D. Yundt, Susanne Fritsch, et al.. (2002). Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain. 125(3). 595–607. 357 indexed citations
15.
Derdeyn, Colin P., Anil Khosla, Tom O. Videen, et al.. (2001). Severe Hemodynamic Impairment and Border Zone-Region Infarction. Radiology. 220(1). 195–201. 91 indexed citations
16.
Fritsch, Susanne, et al.. (2000). Schoeniu wort mit süezeme sange : philologische Schriften. E. Schmidt eBooks.
17.
Powers, William J., Colin P. Derdeyn, Susanne Fritsch, et al.. (2000). Benign prognosis of never-symptomatic carotid occlusion. Neurology. 54(4). 878–882. 87 indexed citations
18.
Derdeyn, Colin P., Tom O. Videen, Susanne Fritsch, et al.. (1999). Compensatory Mechanisms for Chronic Cerebral Hypoperfusion in Patients With Carotid Occlusion. Stroke. 30(5). 1019–1024. 89 indexed citations
19.
Derdeyn, Colin P., Tom O. Videen, Kent D. Yundt, et al.. (1999). Count-based PET Method for Predicting Ischemic Stroke in Patients with Symptomatic Carotid Arterial Occlusion. Radiology. 212(2). 499–506. 54 indexed citations
20.
Derdeyn, Colin P., Kent D. Yundt, Susanne Fritsch, et al.. (1998). Temporal Stability of Hemodynamic Stage in Patients with Carotid Artery Occlusion. Rivista di Neuroradiologia. 11(2_suppl). 202–206.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald Alberico Breakdown of academic impact, for papers by Bruce L. Dean Breakdown of academic impact, for papers by M. Cellerini Breakdown of academic impact, for papers by Wajanat Jan Breakdown of academic impact, for papers by Moshe Snir Breakdown of academic impact, for papers by J Roland Breakdown of academic impact, for papers by Axel Scherer Breakdown of academic impact, for papers by Patrizia Nencini Breakdown of academic impact, for papers by Jean‐Marc Dumollard Breakdown of academic impact, for papers by D. W. Laster
Rankless by CCL
2026